Related Experiment Video
Updated: Aug 12, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells
Yue Liu1, Yong Sun1, Yuliang Xu1
1Department of Natural Products Chemistry, Key Laboratory of Natural Products & Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.
Abstract:
The homotypic fusion and vacuole protein sorting (HOPS) complex mediates membrane trafficking involved in endocytosis, autophagy, lysosome biogenesis, and phagocytosis. Defects in HOPS subunits are associated with various forms of cancer, but their potential as drug targets has rarely been examined. Here, we identified vacuolar protein sorting-associated protein 41 homolog (VPS41), a subunit of the HOPS complex, as a target of methyl 2,4-dihydroxy-3-(3-methyl-2-butenyl)-6-phenethylbenzoate (DMBP), a natural small molecule with preferable anticancer activity. DMBP induced methuosis and inhibited autophagic flux in cancer cells by inhibiting the function of VPS41, leading to the restrained fusion of late endosomes and autophagosomes with lysosomes. Moreover, DMBP effectively inhibited metastasis in a mouse metastatic melanoma model. Collectively, the current work revealed that targeting VPS41 would provide a valuable method of inhibiting cancer proliferation through methuosis.
Insights
Methyl 2,4-dihydroxy-3-(3-methyl-2-butenyl)-6-phenethylbenzoate (DMBP) targets vacuolar protein sorting-associated protein 41 homolog (VPS41), inhibiting cancer cell proliferation via methuosis and restraining metastasis.
Area of Science:
- Cell Biology
- Molecular Oncology
- Drug Discovery
Background:
- The homotypic fusion and vacuole protein sorting (HOPS) complex is crucial for membrane trafficking in cellular processes like endocytosis and autophagy.
- Dysfunction of HOPS subunits is linked to cancer, yet their therapeutic potential remains underexplored.
Purpose of the Study:
- To investigate the anticancer mechanisms of methyl 2,4-dihydroxy-3-(3-methyl-2-butenyl)-6-phenethylbenzoate (DMBP).
- To identify vacuolar protein sorting-associated protein 41 homolog (VPS41) as a key target of DMBP in cancer cells.
Main Methods:
- Identified VPS41 as a direct target of the natural compound DMBP.
- Investigated DMBP's effects on cancer cell phenotypes, including methuosis induction and autophagic flux inhibition.
- Assessed DMBP's efficacy in a mouse model of metastatic melanoma.
Main Results:
- DMBP inhibits VPS41 function, leading to methuosis and impaired autophagic flux in cancer cells.
- DMBP restricts the fusion of late endosomes and autophagosomes with lysosomes.
- DMBP demonstrated significant inhibition of metastasis in a preclinical mouse model.
Conclusions:
- Targeting VPS41 with DMBP represents a novel therapeutic strategy against cancer proliferation.
- DMBP-induced methuosis offers a potential pathway for developing new anticancer treatments.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway

